Luteal support in reproduction: When, what and how?

Current Opinion in Obstetrics and Gynecology

Volumn 21, Issue 3, 2009, Pages 279-284

  Aboulghar, Mohamed ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b EGYPTIAN IVF ET CENTER   (Egypt)

Author keywords

Estrogen; Human chorionic gonadotropin; Luteal phase support; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; ENDOMETRIN; ESTRADIOL VALERATE; GONADORELIN ANTAGONIST; PROGESTERONE; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

CONSENSUS; ECHOGRAPHY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; GESTATIONAL AGE; HUMAN; LUTEAL PHASE; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PREGNANCY TEST; PRIORITY JOURNAL; REPRODUCTION; REVIEW; RISK FACTOR;

DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILIZATION IN VITRO; HUMANS; LUTEAL PHASE; LUTEINIZATION; PRACTICE GUIDELINES AS TOPIC; PROGESTERONE; PROGESTINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67650495190     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32832952ab     Document Type: Review

References (31)

1. Hughes EG, Fedorkow DM, Daya S, et al. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallo-pian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992; 58:888-896.
2. Soliman S, Daya S, Collins J, et al. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61:1068-1076.
3. Nosarka S, Kruger T, Siebert I, et al. Luteal phase support in in vitro fertilization: meta-analysis of randomized trials. Gynecol Obstet Invest 2005; 50:67-74.
4. Macklon NS, Fauser BC. Impact of ovarian hyperstimulation on the luteal phase. J Reprod Fertil Suppl 2000; 55:101-108.
5. Beckers NG, Macklon NS, Eijkemans MJ, et al. Nonsupplemented luteal phase characteristics afterthe administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin- releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 2003; 88:4186-4192.
6. Ludwig M, Finas A, Katalinic A, et al. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support. Acta Obstet Gynecol Scand 2001; 80:574-582.
7. Fujimoto A, Osuga Y, Fujiwara T, et al. Human chrionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles. J Assist Reprod Genet 2002; 19:550-554.
8. Araujo E Jr, Bernardini L, Frederick JL, et al. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction. J Assist Reprod Genet 1994; 11:74-78.
9. Artini PG, Volpe A, Angioni S, et al. A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program. J Endocrinol Invest 1995; 18:51-56.
10. Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a metaanalysis of the randomized trials. Hum Reprod 2002; 17:2287-2299.
11. Daya S, Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev 2004:CD004830.
12. Propst AM, Hill JA, Ginsburg ES, etal.A randomized study comparing crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertil Steril 2001; 76:1144-1149.
13. Anserini P, Costa M, Remorgida V, et al. Luteal phase support in assisted reproductive cycles using either vaginal (crinone 8%) or intramuscular (pron-togest) progesterone: results of a prospective randomized study. Minerva Ginecol 2001; 53:297-301.
14. Abate A, Perino M, Abate FG, et al. Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer. A comparative randomized study. Clin Exp Obstet Gynecol 1999; 26:203-206.
15. Yanushpoisky E, Hurwitz S, Greenberg L, et al. Comparison of crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. Fertil Steril 2008; 89:458-467.
16. Doody K, Shamma FN, Paulson RJ, et al. Endometrin for luteal phase support in a randomized, controlled, open label, prospective IVF clinical trial using a combination of menopur and bravelle. Fertil Steril 2007; 87 (S2):S24.
17. HudayterZR, MuasherSJ. Luteal supplementation in in vitro fertilization: more questions than answers. Fertil Steril 2008; 89:749-757.
18. Iwase A, Ando H, Toda S, et al. Oral progestogen versus intramuscular progesterone for luteal support after assisted reproductive technology treatment: a prospective randomized study. Arch Gynecol Obstet 2008; 277:319-324.
19. Licciardi FL, Kwiatkowski A, Noyes NL, et al. Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. Fertil Steril 1999; 71:614-618.
20. Fatemi HM, Kolibianakis EM, Camus M, et al. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod 2006; 21:2628-2632.
21. Fatemi HM, Camus M, Kolibianakis EM, et al. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertil Steril 2007; 87:504-508.
22. Engmann L, DiLuigi A, Schmidt D, et al. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertil Steril 2008; 89:554-561.
23. Kolibianakis EM, Venetis CA, Papanikolaou EG, et al. Estrogen addition to progesterone for luteal phase support in cycles stimulated with GnRH analogues and gonadotrophins for IVF: a systematic review and metaanalysis. Hum Reprod 2008; 23:1346-1354.
24. Pirard C, Donnez J, Loumaye E. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Hum Reprod 2006; 21:1894-1900.
25. Ata B, Yakin K, Balaban B, et al. GnRH agonist protocol administration in the luteal phaseinICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study. Hum Reprod 2008; 23:668-673.
26. Tesarik J, Hazout A, Mendoza-Tesarik R, et al. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod 2006; 21:2572-2579.
27. Vlaisavljevic V. Embryo transfer and luteal support in natural cycles. Reprod Biomed Online 2007; 14:686-692.
28. Mochtar MH, Van Wely M, Van der Veen F. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles. Hum Reprod 2006; 21:905-908.
29. Schmidt KL, Ziebe S, Popovic B, et al. Progesterone supplementation during early gestation after in vitro fertilization has no effect on the delivery rate. Fertil Steril 2001; 75:337-341.
30. Andersen AN, Popovic-Todorovic B, Schmidt KT, et al. Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Hum Reprod 2002; 17:357-361.
31. Aboulghar MA, Amin Y, Al-Inany H, et al. Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with an additional three weeks. Hum Reprod 2008; 33:857-862.